CONCLUSIONS	In this study of 12 healthy adult male volunteers , the absolute bioavailability of rosiglitazone was 99 % , and the oral and IV single-dose pharmacokinetics of rosiglitazone were unaltered by concurrent treatment with ranitidine .\